MRUS - Merus - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

2.862B

Cash

337.5M

Avg Qtr Burn

-37.46M

Short % of Float

14.98%

Insider Ownership

6.51%

Institutional Own.

78.85%

Qtr Updated

03/31/24

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Zenocutuzumab (MCLA-128 ) (ADCC) Details Cancer, Solid tumor/s, Non-small cell lung carcinoma, Pancreatic cancer	PDUFA Approval decision	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Petosemtamab (MCLA-158) (Lgr5 x EGFR Biclonics®) + Keytruda Details Solid tumor/s, Cancer, Head and neck squamous cell carcinoma	Phase 2/3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Petosemtamab (MCLA-158) (Lgr5 x EGFR Biclonics®) in comb w/ Chemo Details Solid tumor/s, Cancer, Metastatic colorectal cancer	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MCLA-129 (EGFR x c-MET Biclonics®) + osimertinib Details Solid tumor/s, Cancer, Non-small cell lung carcinoma	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
MCLA-145 (CD137 x PD-L1 Biclonics®) + Keytruda Details Cancer, Solid tumor/s	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.